The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative Oncology Group study.
 
Amanda Psyrri
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Genesis Pharmaceuticals; Merck Serono; MSD Oncology; Pfizer; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer; Rakuten Medical
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
George Papaxoinis
No Relationships to Disclose
 
Niki Gavrielatou
No Relationships to Disclose
 
Maria Gkotzamanidou
No Relationships to Disclose
 
Panagiota Economopoulou
No Relationships to Disclose
 
Ioannis Kotsantis
No Relationships to Disclose
 
Aris Spathis
No Relationships to Disclose
 
Maria Anastasiou
No Relationships to Disclose
 
Stavros Gkolfinopoulos
No Relationships to Disclose
 
Martha Nifora
No Relationships to Disclose
 
George Fountzilas
Stock and Other Ownership Interests - ARIAD (I); Deciphera (I); Genprex (I)
Honoraria - AstraZeneca
Consulting or Advisory Role - Pfizer; Roche; Sanofi
Speakers' Bureau - LEO Pharma (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - K.A.M Oncology/Hematology (I); Merck (I); Pfizer (I)
 
Periklis Foukas
No Relationships to Disclose